Clinical Trials Browser

Phase 3 × ferumoxtran-10 × 1 year × Clear all

NCT04261777 2025-06-03

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Phase 3 Terminated

Neoplasm Metastasis, Prostatic Neoplasms